Text Size

MobileMedMinder: A Networked Aide for Medication Compliances

This study is currently recruiting participants.
Verified May 2012 by University of Maryland
Sponsor:
Collaborator:
Limaging
Information provided by (Responsible Party):
Steve Gottlieb, University of Maryland
ClinicalTrials.gov Identifier:
NCT01597583
First received: May 10, 2012
Last updated: May 11, 2012
Last verified: May 2012
History of Changes
  Purpose

The main aim of this study is to conduct a randomized control trial to compare MobileMedMinder, a mobile phone based medication reminder software product, with currently accepted and empirically supported methods for increasing medication compliance through reminders and tracking.


Condition Intervention
Heart Failure, Congestive
 Behavioral: Use of MobileMedMinder

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: MobileMedMinder: A Networked Aide for Medication Compliances

Resource links provided by NLM:

MedlinePlus related topics: Heart Failure
U.S. FDA Resources

Further study details as provided by University of Maryland:

Primary Outcome Measures:
  • Compliance [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    Pill counts will be used to assess compliance


Estimated Enrollment: 50
Study Start Date: November 2011
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Use of MobileMedMinder Behavioral: Use of MobileMedMinder
Use of an intervention to remind patients to take their medications.
No Intervention: Usual care Behavioral: Use of MobileMedMinder
Use of an intervention to remind patients to take their medications.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Taking beta blockers, ACE or ARB, and hydralazine for treatment of HF.

Exclusion Criteria:

  • Inability to understand informed consent
  • Inability to read and understand English
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01597583

Contacts
Contact: Stephen Gottlieb, MD 410-328-8788 sgottlie@medicine.umaryland.edu

Locations
United States, Maryland
University of Maryland Recruiting
Baltimore, Maryland, United States, 21201
Contact: Stephen Gottlieb, MD     410-328-8788     sgottlie@medicine.umaryland.edu    
Sponsors and Collaborators
University of Maryland
Limaging
  More Information

No publications provided

Responsible Party: Steve Gottlieb, Professor, University of Maryland
ClinicalTrials.gov Identifier: NCT01597583     History of Changes
Other Study ID Numbers: HP-00051021
Study First Received: May 10, 2012
Last Updated: May 11, 2012
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 22, 2013